,16 Next, tumor-bearing mice were intravenously injected with either targeted RGD4C.PDP-sTRAIL or non-targeted PDP-sTRAIL at a dose of 5 × 1010 TU per mouse, twice a week. Here, PDP1 is linked to neoplasm.